omeprazole and acenocoumarol

omeprazole has been researched along with acenocoumarol in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Beysens, AJ; de Hoon, JN; Thijssen, HH; Van Bortel, LM1
De Vlaam-Schluter, GM; Snel, P; Trienekens, PH; Tytgat, GN; Vreeburg, EM1
Becker, ML; Franken, WP; Karapinar, F; Schalekamp, T; van der Hoeven, RT; Verzijl-Zeegers, R1
Lozano, R1

Trials

1 trial(s) available for omeprazole and acenocoumarol

ArticleYear
No effect of short-term omeprazole intake on acenocoumarol pharmacokinetics and pharmacodynamics.
    British journal of clinical pharmacology, 1997, Volume: 44, Issue:4

    Topics: Acenocoumarol; Adult; Anticoagulants; Area Under Curve; Biological Availability; Double-Blind Method; Drug Interactions; Half-Life; Humans; Male; Metabolic Clearance Rate; Omeprazole; Prothrombin Time; Stereoisomerism

1997

Other Studies

5 other study(ies) available for omeprazole and acenocoumarol

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Lack of effect of omeprazole in oral acenocoumarol anticoagulant therapy.
    Scandinavian journal of gastroenterology, 1997, Volume: 32, Issue:10

    Topics: Acenocoumarol; Administration, Oral; Aged; Anti-Ulcer Agents; Anticoagulants; Case-Control Studies; Drug Interactions; Female; Humans; Liver; Male; Omeprazole; Peptic Ulcer; Retrospective Studies

1997
Possible drug-drug interaction between high-dose esomeprazole and phenprocoumon.
    European journal of clinical pharmacology, 2015, Volume: 71, Issue:12

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acenocoumarol; Aged; Aged, 80 and over; Anti-Ulcer Agents; Anticoagulants; Dose-Response Relationship, Drug; Drug Interactions; Esomeprazole; Female; Hospitalization; Hospitals, Teaching; Humans; International Normalized Ratio; Male; Omeprazole; Pantoprazole; Phenprocoumon

2015
Drug-drug interactions between acenocoumarol and proton pump inhibitors in hospitalized patients: Overanticoagulation associated with intravenous omeprazole.
    International journal of clinical pharmacology and therapeutics, 2021, Volume: 59, Issue:10

    Topics: Acenocoumarol; Drug Interactions; Enzyme Inhibitors; Humans; Omeprazole; Pharmaceutical Preparations; Proton Pump Inhibitors

2021